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Aminoacylation of tRNA is the cellular process to provide aminoacyl donors for the
ribosome synthesis of polypeptides. New research highlights an unexpected structural
overlap between enzymes involved in this process and those involved in the
biosynthesis of cyclodipeptides, an important class of bioactive molecules.

The canonical role of tRNA in ribosomal protein synthesis begins with aminoacylation catalyzed
by aminoacyl-tRNA synthetases (aaRSs). Each aaRS activates its cognate amino acid with ATP
and esterifies the intermediate aminoacyl-AMP (aa-AMP) to the 3’ terminal ribose of tRNA to
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form the product aminoacyl-tRNA (aa-tRNA), which enters the ribosome according to the tRNA
anticodon. Although the ribosome machinery is highly efficient, thanks to protein factors that
ensure rapid capture of aa-tRNA to support protein synthesis, recent work has shown that some
aa-tRNAs can escape capture and instead participate in peptide synthesis outside the
ribosome. For example, cyclodipeptide synthases (CDPSs) hijack aa-tRNAs to make
cyclodipeptides1 (Fig.1a), but how they accomplish this task was unknown. One page xx of this
issue2, Blanchard and colleagues report the crystal structure of one of these enzymes, revealing
a surprising homology to aaRSs with interesting new insights into the mechanism of making
cyclodipeptides from aa-tRNAs.

Cyclodipeptides and their derivatives are important diketopiperazine compounds with diverse
biodefense activities; hence an understanding of their biosynthesis is expected to impact human
health. While most cyclodipeptides are synthesized by the large non-ribosome peptide
synthetases in microorganisms, albonoursin biosynthesis relies on a small enzyme, the AlbC
protein of Streptomyces noursei, to synthesize the cyclodipeptide precursor cyclo(L-Phe-L-Leu)
(cFL)3. The AlbC activity is unorthodox1; it does not use free L-phenylalanine and L-leucine as
substrates, but instead requires the pre-charged Phe-tRNAPhe and Leu-tRNALeu. This unusual
activity explains the lack of an ATP-binding motif in AlbC and relates it to proteins of two other
families that use aa-tRNAs to make peptides: aa-tRNA protein transferases4 and aminoacyl
transferases5. An in silico search has identified several AlbC homologues1, with subsequent
biochemical experiments confirming their CDPS activity1. One of these is Rv2275 from
Mycobacterium tuberculosis, which uses two molecules of Tyr-tRNATyr to synthesize cyclo(LTyr-L-Tyr) (cYY) as an intermediate in mycocyclosin biosynthesis.

Although a recent protein sequence profile analysis has suggested that CDPSs may be related
to the aa-tRNA-synthesizing aaRSs6, the low homology between the two families of enzymes
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precluded any speculation as to the structural features of CDPSs. Thus, the crystal structure of
Rv2275 provided by Blanchard and colleagues is a surprise: the protein is structurally most
closely related to TyrRS and TrpRS, the class Ic members of aaRSs. The aaRSs have been
divided into two major classes according to their ATP-binding motifs: class I enzymes use the
common protein fold known as the Rossmann fold to bind ATP for generating the intermediate
aa-AMP and converting it to aa-tRNA, whereas class II enzymes bind ATP in an antiparallel
core of β-strands. Unlike the monomeric structure of all other class I enzymes, class Ic enzymes
are distinguished by a dimeric structure with the two active sites interdigitated at the dimer
interface. Rv2275 is also a dimer, possessing similarly arranged active sites while containing
notable structural rearrangements that would block ATP binding (Fig.1b). Importantly, of the
many conserved CDPS-signature residues that cluster near a putative amino acid-binding
pocket of Rv2275 is Ser88, whose spatial position is a determinant of the ATP-independent
active site and is relevant to catalysis. Indeed, the alanine substitution of Ser88 completely
abolishes the enzyme activity and prevents the formation of a crucial reaction intermediate. This
intermediate, when formed In the wild-type Rv2275 after incubation with [14C]-Tyr-tRNATyr and
separation of the tRNA, contains the radiolabel and is stable enough to survive even in
denaturing condition with 5 M urea, suggesting that it is a tyrosinylated covalent enzyme
complex. These observations form the basis for a proposed mechanism of Rv2275 that may be
generalizable to other CDPSs.

In the proposed mechanism (Fig.1a), the Ser88 hydroxyl performs nucleophilic attack on the
carbonyl ester of the first aa1-tRNA1, leading to the formation of the covalent enzyme-aa1
intermediate and the release of the deacylated tRNA1. Structural data suggest that the active
site should rearrange to accommodate the entry of a second aa2-tRNA2, upon which the αamino group of the tRNA-bound aa2 would attack the enzyme-bound aa1 to generate the tRNA-
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bound dipeptide aa1-aa2. Following a second nucleophilic attack by the α-amino group of aa1 on
the carbonyl ester of aa2 is the formation of the product cyclodipeptide and the release of tRNA2.
Mutational analysis implicates the involvement of a general base in the active site (the CDPSsignature residue E233 of Rv2275) that would accelerate proton abstraction of the α-amino
group of aa2-tRNA2 to promote nucleophilic attack and would also assist in the protonation of
the deacylated tRNA2 to facilitate product release.

The proposed mechanism highlights two remarkable features of making cyclodipeptides on
tRNA. One is the sequential use of aa-tRNAs as the donors of already activated amino acids,
thus affording CDPSs with a small structure (without the amino-acid activation domain) to
catalyze a complex reaction. The second is the covalent trapping of the first amino acid on
CDPSs while arranging the second aa-tRNA for the chemistry step. This covalent strategy may
be necessary to compete for the cellular pools of aa-tRNAs, which after synthesis on aaRSs are
typically captured by elongation factor EF-Tu for rapid delivery to the ribosome. However, even
with the first amino acid stabilized, the competition for the second aa-tRNA is formidably more
challenging because the covalent mechanism is no longer invoked. Intriguingly, their structural
homology to class Ic aaRSs suggests that CDPSs should bind aa-tRNA favorably, because
class I aaRSs generally exhibit preferentially high affinities to the aa-tRNA product7, and
because the dimeric Ic structure has been suggested to serve as a barrier to prevent direct
release of aa-tRNA to EF-Tu7. These considerations provide a useful framework to appreciate
the unexpected structural homology.

The current structure should be a springboard to jump start additional structural work on the
CDPS enzymes, preferably in complexes with bound substrates. Such structures will help to
address unresolved questions, pertaining to their selectivity of aa-tRNA, the determinants for the
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sequential entry of aa-tRNA, and the operational relationship of the two active sites. Together
with more detailed biochemical analysis, new insights are likely to emerge enabling the design
of novel cyclodipeptides for medical purposes.
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Legend to Figure 1:
(a) Peptide synthesis from aminoacyl-tRNAs. Aminoacylation of a tRNA by an aaRS (blue),
using an amino acid (aa) and ATP as substrates, generates an aa-tRNA that is typically
released to GTP-bound EF-Tu (purple) and delivered to the ribosome (grey) for synthesis of a
new peptide bond on a nascent polypeptide. However, some aa-tRNAs are hijacked by CDPSs
(green) to make cyclodipeptides, using a covalent trapping strategy that fixes the aa from the
first aa-tRNA (red) on the enzyme while making a dipeptide with the second aa-tRNA (metallic).

(b) Structural homology of Rv2275 and TyrRS. The active site of Rv2275 contains a putative
amino acid-binding site (aa site) structurally homologous with the aa site of the class Ic TyrRS,
but features a “closed” loop conformation (blue) that would block ATP binding as opposed to the
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“open” loop conformation of the ATP site in TyrRS. Drawn with PyMol based on coordinates of
Rv2275 (PDB 2X9Q) and TyrRS (PDB 1VBM).
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